James Martin
James has experience in all aspects of complex antitrust, commercial, and financial services litigation on a national and international scale. He has represented corporations, financial institutions, and federal agencies in high stakes litigation ranging from cartels to monopolization. James has represented companies that “opted out” of price-fixing class actions in the markets for vitamins, feed additives, corrugated boxes, urethane chemicals, and the pharmaceutical sector, all of which were resolved in favor of his clients with aggregate recoveries exceeding $2 billion. Jim has also worked on the defense side of the “v,” representing companies accused of antitrust violations and insurers in COVID-19 class action litigation. Recently, Jim has also worked with national insurance industry associations to file numerous amicus briefs in courts around the country regarding COVID-19 business interruption cases. James is a frequent speaker and author. In 2015, he received the distinguished Burton Award as one of the nation’s top legal writers.